JAS 2012 GL Calls for Consideration of Medication for Primary Prevention in Patients with LDL-C Levels Over 180 mg/dL

The Japan Atherosclerosis Society (JAS) announced at a forum held in Kagoshima City on February 5 the outline of the “prevention guideline (GL) for arteriosclerotic disease 2012”, for which the revision is in progress. The GL will indicate that medication...read more